2023. Circulating Tumor DNA as an Early Biomarker of Efficacy of Targeted and Chemotherapy. Voprosy onkologii. 69, 5 (Nov. 2023), 796–804. DOI:https://doi.org/10.37469/0507-3758-2023-69-5-796-804.